{"disease":{"id":"post-acute-covid-19-respiratory-disease","name":"post acute covid 19 respiratory disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04652518","title":"LYT-100 in Post-acute COVID-19 Respiratory Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":185,"lead_sponsor_name":"PureTech","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}